A recent editorial in BioCentury by author Steve Usdin shines a light on a serious new threat to the very foundation of American science.
At issue is a proposed Office of Management and Budget rule that would give political appointees veto power over federal research grants, effectively sidelining the scientific experts best positioned to evaluate which research deserves funding. Usdin makes a compelling case for why those who understand what’s at stake must speak up.
At the Scleroderma Research Foundation, we believe that rigorous, science-driven decision-making is what makes breakthroughs possible. As the nation’s leading nonprofit investor in scleroderma research, we stand with the broader scientific community and remain unwavering in our mission to end scleroderma.
